Hepatitis

BC-CfE researchers examine HCV knowledge and awareness of reinfection risk among people successfully treated with direct acting antiviral therapy

The Hepatitis C virus (HCV) is a blood borne infection and a leading cause of end-stage liver disease. The World Health Organization estimates that about 58 million people are living with chronic HCV, leading to 290,000 deaths annually due to HCV-related liver illness. Here in Canada, HCV affects a quarter of a million people. Of this quarter million, over 40% are unaware of their infection.

BC-CfE researchers examine HCV knowledge and awareness of reinfection risk among people successfully treated with direct acting antiviral therapy Read More »

BC-CfE Researchers help fight drug resistance to Hepatitis C treatments

A new research paper published by the BC-CfE laboratory’s scientists will help healthcare providers improve treatments for people living with the hepatitis C virus (HCV). The study, led by Dr. Hope Lapointe, describes a new test that physicians can use to help “personalize” their patients’ HCV treatment.

BC-CfE Researchers help fight drug resistance to Hepatitis C treatments Read More »

BC-CfE researchers attend world’s most influential meeting on HIV research

The 11th International AIDS Society (IAS) Conference on HIV Science took place from July 18th to the 21st and BC-CfE researchers attending the virtual conference used the opportunity to present their latest findings. Taking place virtually from Berlin, IAS 2021 saw around 6,000 participants and opened with remarks from German Chancellor Angela Merkel and included

BC-CfE researchers attend world’s most influential meeting on HIV research Read More »

BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar

The BC-CfE’s Nance Cunningham, an Experimental Medicine PhD student working in the EMBARC team (Epidemiological, Mathematical and Biostatistical analysis and Research Collaboration in HIV/AIDS) has been chosen as a UBC Public Scholar.The Public Scholars Initiative (PSI)supports creative, action-oriented research designed to address complex challenges and have meaningful public impact as part of a PhD thesis. The award will support Cunningham’s research partnerships with people affected by hepatitis C, and patient advocacy activists.

BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar Read More »

Power combo: Harm reduction plus effective treatment help prevent spread of Hepatitis C

Fifty-three year old Vancouver resident Sage Rinaldo lived with hepatitis C for many years before working up the courage to seek treatment. Rinaldo credits a community health nurse in the Downtown Eastside who gained her trust and helped her successfully treat her hepatitis C with a new anti-viral treatment. Now, Rinaldo is giving back by

Power combo: Harm reduction plus effective treatment help prevent spread of Hepatitis C Read More »

The BC-CfE’s Per-SVR Team Fights for HCV Awareness

Globally, 290 million people are unaware they are living with a hepatitis C virus (HCV) infection. This significant global health problem affects as many as 80,000 individuals here in BC. Today on World Hepatitis Day, the theme is ‘Find the Missing Millions’ in order to raise awareness of the global burden of viral hepatitis and to influence real change.

The BC-CfE’s Per-SVR Team Fights for HCV Awareness Read More »